Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges最新文献

筛选
英文 中文
Molecular Basis of DNA Repair Defects in FUS-Associated ALS: Implications of a New Paradigm and Its Potential as Therapeutic Target FUS-Associated ALS DNA修复缺陷的分子基础:新范式的意义及其作为治疗靶点的潜力
Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges Pub Date : 2020-06-18 DOI: 10.5772/intechopen.92637
Haibo Wang, M. Hegde
{"title":"Molecular Basis of DNA Repair Defects in FUS-Associated ALS: Implications of a New Paradigm and Its Potential as Therapeutic Target","authors":"Haibo Wang, M. Hegde","doi":"10.5772/intechopen.92637","DOIUrl":"https://doi.org/10.5772/intechopen.92637","url":null,"abstract":"Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disorder, characterized by a diverse etiopathology. While ALS is predominantly sporadic, mutations in one or more of a dozen risk factors have been linked to approximately 10% of familial ALS patients. The multifunctional RNA/DNA-binding protein fused in sarcoma (FUS) is one such protein whose autosomal dominant missense mutations were identified in a subset of familial and sporadic ALS patients. Initial studies linked FUS with both RNA-related and genome maintenance functions, yet the mechanisms and potential implications to neurodegeneration were not completely understood. We recently identified a novel function of FUS in repair-ing single-strand break (SSB) in the genome. FUS directly interacts and recruits XRCC1/DNA Ligase III α (LigIII) to DNA oxidative damage sites in a PARP1 activity-dependent manner, which facilitates optimal oxidative genome damage repair. Besides, FUS regulates DNA strand break sealing by enhancing ligation activity of LigIII. The mutation of FUS induces accumulation of oxidative DNA damage as well as DNA repair deficiency in ALS patients. The novel findings provide insights into a previously undescribed mechanism of DNA repair defect in FUS-associated neurodegeneration, and raise the pentientials of developing neuroprotective therapies by targeting DNA break ligating defects.","PeriodicalId":350123,"journal":{"name":"Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges","volume":"74 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127179016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of TDP-43 in Genome Repair and beyond in Amyotrophic Lateral Sclerosis 肌萎缩性侧索硬化症中TDP-43在基因组修复及其他方面的作用
Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges Pub Date : 2020-06-03 DOI: 10.5772/intechopen.92696
J. Mitra, M. Hegde
{"title":"The Role of TDP-43 in Genome Repair and beyond in Amyotrophic Lateral Sclerosis","authors":"J. Mitra, M. Hegde","doi":"10.5772/intechopen.92696","DOIUrl":"https://doi.org/10.5772/intechopen.92696","url":null,"abstract":"The pathology of the RNA-/DNA-binding protein TDP-43, first implicated a decade ago in the motor neuron disease amyotrophic lateral sclerosis (ALS), has been subsequently linked to a wide spectrum of neurodegenerative diseases, including frontotemporal dementia (FTD), Alzheimer’s disease (AD), and related demen-tia-associated disorders. ALS, also known as Lou Gehrig’s disease, is a progressive, degenerative motor neuron disorder, characterized by a diverse etiopathology. TDP-43 pathology, mediated by a combination of several mutations in the TARDBP gene and stress factors, has been linked to more than 97% of ALS patients. We recently identified, for the first time, the critical involvement of TDP-43 in neuronal genome maintenance and the repair of DNA double-strand breaks (DSBs). Our studies showed that TDP-43 regulates the DNA break-sealing activities of the XRCC4-DNA Ligase 4 (LIG4) complex in DSB repair, suggesting that loss of genomic integrity in TDP-43-associated neurodegeneration may be amenable to a DNA repair-based intervention. In this chapter, we discuss the broader aspects of TDP-43 toxicity-induced pathomechanisms, including the emerging role of TDP-43 in neuronal DSB repair and its synergistic genotoxic effects with other neurodegeneration-associated etiologies that contribute significantly to neuronal dysfunction. We also discuss potential future perspectives and underscore how unraveling the molecular basis and implications of TDP-43-induced genome instability in ALS could guide the development of neuroprotective therapies. healthy condition, TDP-43 strongly promotes normal splicing events and inhibits disease-causing aberrant alternative splicing. However, ALS/FTD-TDP-43 pathology induces aberrant splicing several folds higher than normal splicing leading to mRNA dysregulation-associated proteinopathies in motor neurons and glia. Moreover, exposure to various environmental toxins like heavy metals (Lead, iron, zinc), pesticides (organochloride compounds), and food toxins (BMAA) could cause pathogenic alterations in TDP-43 leading to its mislocalization and dysregulation of its splicing activity as a result causing sporadic ALS.","PeriodicalId":350123,"journal":{"name":"Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114726272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Targeting Axonal Transport: A New Therapeutic Avenue for ALS 靶向轴突转运:治疗ALS的新途径
Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges Pub Date : 2020-04-15 DOI: 10.5772/intechopen.91963
Wenting Guo, L. Fumagalli, L. Bosch
{"title":"Targeting Axonal Transport: A New Therapeutic Avenue for ALS","authors":"Wenting Guo, L. Fumagalli, L. Bosch","doi":"10.5772/intechopen.91963","DOIUrl":"https://doi.org/10.5772/intechopen.91963","url":null,"abstract":"Motor neurons have an extreme polarized morphology and heavily rely on efficient cargo transport along axons to maintain their neuronal connections and connections with muscles. Axonal transport deficits have been observed in almost all model systems of ALS. More and more studies have confirmed the close genetic and mechanistic linkage between axonal transport deficits with ALS pathogenesis. Moreover, several therapeutic approaches have been developed to target axonal transport deficits in ALS and showed promising effects in disease models. In this concise chapter, we summarize some major discoveries of axonal transport deficits in ALS pathogenesis and some related therapeutic strategies. We propose that targeting axonal transport may provide a potential therapeutic avenue for ALS.","PeriodicalId":350123,"journal":{"name":"Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges","volume":"129 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133660831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Role of Extracellular Vesicles in the Progression of ALS and Their Potential as Biomarkers and Therapeutic Agents with Which to Combat the Disease 细胞外囊泡在ALS进展中的作用及其作为生物标志物和治疗药物的潜力
Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges Pub Date : 2020-03-10 DOI: 10.5772/INTECHOPEN.91388
Changho Chun, Alec S.T. Smith, M. Bothwell, D. Mack
{"title":"The Role of Extracellular Vesicles in the Progression of ALS and Their Potential as Biomarkers and Therapeutic Agents with Which to Combat the Disease","authors":"Changho Chun, Alec S.T. Smith, M. Bothwell, D. Mack","doi":"10.5772/INTECHOPEN.91388","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.91388","url":null,"abstract":"Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that impairs motor neuron function, leading to severe muscular atrophy. The non-cell autonomous and heterogeneous nature of the disease has so far hindered attempts to define ALS etiology, leaving the disease incurable and without effective treatments. Recent studies have focused on the pathologic role of intercellular communication between nerve cells to further our understanding of ALS pathophysiology. In this chapter, we summarize recent works investigating the role of extracellular vesicles (EVs) as a means of cellular crosstalk for ALS disease propagation, diagnosis, and treatment. There is growing evidence that EVs secreted by the majority of mammalian cells serve as effective biomolecule carriers to modulate recipient cell behavior. This underscores the need to understand the EV-mediated interplay that occurs within irreversibly degenerating nervous tissue in ALS patients. Addition-ally, we highlight current gaps in EV-ALS research, especially in terms of the pathologic role and responsibilities of specific EV cargos in diseased cells, specificity issues associated with the use of EVs in ALS diagnosis, and the efficacy of EV-mediated treatments for the restoration of diseased neuromuscular tissue. Finally, we provide suggestions for future EV-ALS research to better understand, diagnose, and cure this inveterate disease.","PeriodicalId":350123,"journal":{"name":"Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges","volume":"148 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127243829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Senataxin: A Putative RNA: DNA Helicase Mutated in ALS4—Emerging Mechanisms of Genome Stability in Motor Neurons Senataxin: als4中假定的RNA: DNA解旋酶突变-运动神经元基因组稳定性的新机制
Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges Pub Date : 2020-02-04 DOI: 10.5772/intechopen.90215
Arijit Dutta, R. Hromas, P. Sung
{"title":"Senataxin: A Putative RNA: DNA Helicase Mutated in ALS4—Emerging Mechanisms of Genome Stability in Motor Neurons","authors":"Arijit Dutta, R. Hromas, P. Sung","doi":"10.5772/intechopen.90215","DOIUrl":"https://doi.org/10.5772/intechopen.90215","url":null,"abstract":"Amyotrophic lateral sclerosis type 4 (ALS4) is a rare, autosomal dominant childhood- or adolescent-onset motor neuron disease caused by genetic defects in senataxin (SETX), a putative RNA–DNA helicase. Studies on the yeast SETX ortholog Sen1 revealed its role in small RNA termination pathways. It has been postulated that ALS4-associated neuronal pathologies could stem from defects in RNA metabolism and altered gene expression. Importantly, SETX prevents the accumulation of R-loops, which are potentially pathogenic RNA–DNA hybrids that stem from perturbations in transcription. SETX also interacts with the tumor suppressor BRCA1 that helps promote DNA double-strand break repair by homologous recombination. As such, SETX could contribute toward the removal of harmful R-loops and DSBs in postmitotic neurons. This chapter will visit the plausible mechanistic role of SETX in R-loop removal and DNA break repair that could prevent the activation of apoptotic cell death in neurons and pathological manifestation of ALS4.","PeriodicalId":350123,"journal":{"name":"Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122270502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pathological Interaction between DNA Repair and Mitochondrial Dysfunction in ALS ALS患者DNA修复与线粒体功能障碍的病理相互作用
Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges Pub Date : 2020-01-07 DOI: 10.5772/intechopen.90217
Luis Bermúdez-Guzmán, Alejandro Leal
{"title":"Pathological Interaction between DNA Repair and Mitochondrial Dysfunction in ALS","authors":"Luis Bermúdez-Guzmán, Alejandro Leal","doi":"10.5772/intechopen.90217","DOIUrl":"https://doi.org/10.5772/intechopen.90217","url":null,"abstract":"Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the degeneration of cortical and spinal cord motor neurons. Several mechanisms have been implicated in the pathogenesis of the disease, including mitochondrial dysfunction, oxidative stress, and genome instability. Recently, a combined role between impaired DNA repair and subsequent mitochondrial dysfunction has emerged as a novel pathological interaction in neurodegeneration. This is exempli-fied by mutations in the RNA-/DNA-binding proteins FUS and TDP-43 as well as superoxide dismutase 1 (SOD1) gene, all related to familial ALS. In this regard, evidence supports either downregulation or impaired recruitment of DNA repair enzymes in both nuclear and mitochondrial genomes. In addition, evidence also suggests a complex metabolic dysregulation as a critical component in the promo-tion of the disease. This chapter aims to integrate the molecular mechanisms of this pathological interplay and the possible role in cytosolic protein aggregation and cell death in motor neurons. ,","PeriodicalId":350123,"journal":{"name":"Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges","volume":"114 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126878145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RNA Metabolism and Therapeutics in Amyotrophic Lateral Sclerosis 肌萎缩侧索硬化的RNA代谢和治疗
Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges Pub Date : 2019-12-26 DOI: 10.5772/intechopen.90704
O. Pansarasa, S. Gagliardi, D. Sproviero, Cristina Cereda
{"title":"RNA Metabolism and Therapeutics in Amyotrophic Lateral Sclerosis","authors":"O. Pansarasa, S. Gagliardi, D. Sproviero, Cristina Cereda","doi":"10.5772/intechopen.90704","DOIUrl":"https://doi.org/10.5772/intechopen.90704","url":null,"abstract":"Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disorder characterized by the selective death of upper and lowers motor neurons in spinal cord, brain stem, and motor cortex, which leads to paralysis and death within 2–3 years of onset. Deeply sequencing technologies, to simultaneously analyze the transcriptional expression of thousands of genes, offered new possibilities to focus on ALS pathogenesis and, most notably, to find new potential targets for novel treatments. The present book chapter illustrates recent advances in transcriptomic studies in animal models and human samples and in new molecular targets related to ALS pathogenesis and disease progression. Additionally, new insights into the involvement of altered transcriptional profiles of noncoding RNAs (microRNA and lncRNA) and ALS-associated ribosomal binding proteins have been investigated, to understand the functional consequences of extensive RNA dysregulation in ALS. Attention has been also turned on how transcriptome alterations could highlight new molecular targets for drug development.","PeriodicalId":350123,"journal":{"name":"Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges","volume":"161 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120995556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Extraocular Muscles Are Selectively Spared in ALS 肌萎缩侧索硬化症选择性地保留眼外肌
Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges Pub Date : 2019-10-24 DOI: 10.5772/intechopen.89504
Fátima Pedrosa Domellöf
{"title":"The Extraocular Muscles Are Selectively Spared in ALS","authors":"Fátima Pedrosa Domellöf","doi":"10.5772/intechopen.89504","DOIUrl":"https://doi.org/10.5772/intechopen.89504","url":null,"abstract":"The extraocular muscles differ from other skeletal muscles in many respects but most strikingly in their response to neuromuscular diseases expected to affect the whole body. Oculomotor disturbances are not typical features of ALS. Recent data ascribe the muscle tissue an important role in the pathophysiology of ALS, with early involvement of the neuromuscular junctions and loss of axonal contact. We show that the extraocular muscles of terminal ALS donors and also of mice models of ALS maintain their morphology and well-preserved neuromuscular junctions until the end stages of the disease, whereas the limb muscles are severely affected and their neuromuscular junctions start losing contact with the supplying axons early in the course of ALS. There are intrinsic differences between the extraocular and limb muscles with respect to neurotrophic factors and Wnt isoforms and fundamental differences in their response to ALS that cannot be explained by the aging process. We propose that these differences may be instrumental in the selective sparing of the extraocular muscles in ALS. as an early step toward the loss of the neuromuscular junction in ALS. In summary, this study shows fundamental differences between the and the EOMs of terminal ALS with a significant impact of the","PeriodicalId":350123,"journal":{"name":"Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130819522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书